Given that transient AKT-driven steatosis typically resolves as HCs undergo CCA fate conversion (31, 32), these findings indicate that Sall4 overexpression interferes with HC-to-CCA fate switching by sustaining a progenitor-like, lipid-rich state. The gene discussed is AKT1; the disease is cholangiocarcinoma.